A phase II clinical trial of neoadjuvant chemotherapy combined with immunotherapy and different radiotherapy fractionation regimens in HR+/HER2- breast cancer.

Loqtorzi (toripalimab-tpzi) - Shanghai Junshi Bioscience, Coherus Oncology

http://www.ncbi.nlm.nih.gov/pubmed/42495649

Jie Lan; Jing Jing; Lei Liu; Tin Luo; Wei Huang; Xiaobo Huang; Xiaoyue Sun; Xin Wu; Yanxia Zhao; Zhuofei Bi

Jul 25, 2026